MedPath

RiboCor, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Phase 2
Withdrawn
Conditions
Congestive Heart Failure
Interventions
Other: Placebo
First Posted Date
2013-05-21
Last Posted Date
2016-07-14
Lead Sponsor
RiboCor, Inc.
Registration Number
NCT01858480
Locations
🇺🇸

Long Beach Memorial Medical Center, Long Beach, California, United States

🇺🇸

Novo Research, Inc., Modesto, California, United States

🇺🇸

Olive View-UCLA- Medical Center, Sylmar, California, United States

and more 21 locations

D-Ribose for Fatigue in Subjects With Fibromyalgia

Phase 2
Completed
Conditions
Fibromyalgia
Interventions
Dietary Supplement: Placebo Powder
First Posted Date
2011-03-15
Last Posted Date
2013-09-18
Lead Sponsor
RiboCor, Inc.
Target Recruit Count
110
Registration Number
NCT01315210
Locations
🇺🇸

Superior Research, LLC, Sacramento, California, United States

🇺🇸

Avail Clinical Research, Deland, Florida, United States

🇺🇸

Renstar Medical Research, Ocala, Florida, United States

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.